drug development Archives | Be Korea-savvy
IHMA Announces a New Venture in India to Further Their Global Support of Anti-infective Drug Development for the Biopharmaceutical Industry

IHMA Announces a New Venture in India to Further Their Global Support of Anti-infective Drug Development for the Biopharmaceutical Industry

SCHAUMBURG, Ill., Oct. 31 (Korea Bizwire) — International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a global company that provides laboratory and consultative services to the biopharmaceutical industry involved in the development of products for the prevention, control and treatment of infectious diseases has announced the establishment of an affiliate in India (IHMA India, LLP).  [...]

S. Korea to Use AI in Drug Discovery

S. Korea to Use AI in Drug Discovery

SEOUL, Jun. 7 (Korea Bizwire) — South Korea will spearhead a project to develop a drug platform based on artificial intelligence (AI) and big data, the government said Thursday, in the latest effort to transform the country into a global biotech and medical industry hub. A total of four research centers and universities — the [...]

IHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance Studies

IHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance Studies

SCHAUMBURG, Ill., Mar. 6 (Korea Bizwire) — On 14th October 2017 IHMA Europe Sàrl, located in Monthey, Valais, Switzerland, was awarded accreditation by the College of American Pathologists (CAP).  With this important development both IHMA facilities, located in the US and Europe, are now CAP accredited.  These accreditations further advance IHMA’s global commitment to the [...]